StockData
Immunocore Holdings plc logo

Immunocore Holdings plc (IMCR) stock

IMCRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/3012% below fair value
$28.88−1.06 (-3.54%)

Close on Nov 16, 2026Market cap $1.49BP/E –Yield 0.00%

Immunocore EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Immunocore's EPS for the twelve months ending Jun 30, 2026 was -$0.36. For fiscal 2025 it was -$0.71. The highest annual figure on record is -$0.71 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$0.71–
FY2024Dec 31, 2024-$1.02–
FY2023Dec 31, 2023-$1.13–
FY2022Dec 31, 2022-$1.15–
FY2021Dec 31, 2021-$4.24–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.02–
Q1 FY2026Mar 31, 2026$0.25+150.0%
Q4 FY2025Dec 31, 2025-$0.59–
Q3 FY2025Sep 30, 2025$0.00-100.0%
Q2 FY2025Jun 30, 2025-$0.20–
Q1 FY2025Mar 31, 2025$0.10–
Q4 FY2024Dec 31, 2024-$0.47–
Q3 FY2024Sep 30, 2024$0.17+750.0%
Q2 FY2024Jun 30, 2024-$0.23–
Q1 FY2024Mar 31, 2024-$0.49–
Q4 FY2023Dec 31, 2023-$0.40–
Q3 FY2023Sep 30, 2023$0.02–
Q2 FY2023Jun 30, 2023-$0.35–
Q1 FY2023Mar 31, 2023-$0.40–

More Immunocore figures

See a number that looks wrong?